Inferring the origin of metastases from cancer phylogenies

Cancer Research

Volumn 75, Issue 19, 2015, Pages 4021-4025

  Hong, Woo Suk ^a   Shpak, Max ^b,c,d   Townsend, Jeffrey P ^e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEXAS CARDIAC ARRHYTHMIA INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d Fresh Pond Research Institute Cambridge   (United States)

^e YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANCESTRY GROUP; CANCER GENETICS; CANCER GROWTH; CANCER RESEARCH; GENE MUTATION; GENE SEQUENCE; GENEALOGY; GENETIC TRAIT; GENOTYPE; HUMAN; METASTASIS; METASTASIS POTENTIAL; MOLECULAR CLONING; MOLECULAR EVOLUTION; MONOPHYLY; NATURAL SELECTION; OVARY CANCER; PHENOTYPE; PHYLOGENETIC TREE; PHYLOGENY; POLYPHYLY; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; CELL CLONE; CELL LINEAGE; CELL MOTION; FORECASTING; GENETICS; MUTATION; PATHOLOGY; SINGLE CELL ANALYSIS;

DNA;

CELL LINEAGE; CELL MOVEMENT; CLONE CELLS; DNA, NEOPLASM; FORECASTING; HUMANS; MUTATION; NEOPLASM METASTASIS; SINGLE-CELL ANALYSIS;

EID: 84945578598     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-1889     Document Type: Review

References (28)

1. Shpak M, Churchill GA. The information content of a character under a Markov model of evolution. Mol Phylogenet Evol 2000;17:231-43.
2. Townsend JP. Profiling phylogenetic informativeness. Syst Biol 2006;56: 222-31.
3. Townsend JP, Su Z, Tekle YI. Phylogenetic signal and noise: predicting the power off a data set to resolve phylogeny. Syst Biol 2012;61:835-49.
4. Schwarz RF, Trinh A, Sipos B, Brenton JD, Goldman N, Markowetz F. Phylogenetic quantification of intra-tumour heterogeneity. PLOS Comput Biol 2014;10:e1003535.
5. Schwarz RF, Ng CKY, Cooke SL, Newman S, Temple J, Piskorz AM, et al. Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis. PLOS Med 2015;12:e1001789.
6. Hong MKH, Macintyre G, Wedge DC, Van Loo P, Patel K, Lunke S, et al.. Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer. Nat Commun 2015;6:6605.
7. Gundem G, Van Loo P, Kremeyer B, Alexandrov LB, Tubio JMC, Papaemmanuil E, et al. The evolutionary history of lethalmetastatic prostate cancer. Nature 2015;520:353-6.
8. Budd G. Does evolution in body patterning genes drive morphological change-or vice-vesa? Bioessays 1994;21:326-32.
9. Valentine JW. On the origin of phyla. Chicago, IL: University of Chicago Press; 2004.
10. Fischer A, Vazquez-Garcia I, Illingworth CJR, Mustonen V. High-definition reconstruction of clonal composition in cancer. Cell Rep 2014;7: 1740-52.
11. Martinez F, Lafforgue G, Morelli MJ, Gonzalez-Candelas F, Chua N-H, Daros J-A, Elena SF. Ultradeep sequencing analysis of population dynamics of virus escape mutants in RNAi-mediated resistant plants. Mol Biol Evol 2012;29:3297-307.
12. Zagordi O, Bhattacharya A, Eriksson N, Beerenwinkel N. ShoRAH: estimating the genetic diversity of a mixed sample from next-generation sequence data. BMC Bioinformatics 2011;12:199.
13. Yates LR, Gerstung M, Knappskog S, Desmedt C, Gundem G, Van Loo P, et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat Med 2015;21:751-9.
14. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed bymultiregion sequencing. N Engl J Med. 2012;366:883-92.
15. Tao Y, Ruan J, Yeh S-H, Lu X, Wang Y, Zhai W, et al. Rapid growth of hepatocellular carcinoma and the driving mutations revealed by cellpopulation genetic analysis of whole-genome data. Proc Natl Acad Sci U S A 2011;108:12042-7.
16. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, et al. Distance metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010;467:1114-7.
17. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, et al. Tumour evolution inferred by single-cell sequencing. Nature 2011;472:90-94.
18. Xu X, Hou Y, Yin X, Bao L, Tang A, Song L, et al. Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 2012;148:886-95.
19. Hou Y, Song L, Zhu P, Zhang B, Tao Y, Xu X, et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 2012;148:873-85.
20. Li Y, Xu X, Song L, Hou Y, Li Z, Tsang S, et al. Single-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscleinvasive bladder cancer. GigaScience 2012;1:1-14.
21. Navin N, Hicks J. Future medical applications of single-cell sequencing in cancer. Genome Med 2011;3:31.
22. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organspecific colonization. Nat Rev Cancer 2009;9:274-84.
23. Giese A, Vjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003;21: 1625-36.
24. Bernards R, Weinberg RA. A progression puzzle. Nature 2002;418:823.
25. Felsenstein J. Phylogenies and the comparative method. Am Nat 1984;125: 1-15.
26. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 1989;123:585-95.
27. Fay JC, Wu CI. The neutral theory in the genomic era. Curr Opin Genet Dev 2001;11:642-6.
28. Yang Z, dos Reis M. Statistical properties of the branch-site test of positive selection. Mol Biol Evol 2011;28:1217-28.